Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias

Fig. 2

Changes in clinical parameters before and after PMX-DHP therapy. a, b: White blood cell and neutrophil counts were not significantly different before and after PMX-DHP therapy. c, e: After PMX-DHP, the platelet counts in peripheral blood samples and serum HMGB-1 levels were significantly lower than before PMX-DHP therapy. d: Serum LDH levels were not significantly different before and after PMX-DHP. f: The P/F ratio tended to improve after PMX-DHP, but there were no significant differences between P/F ratio before and after PMX-DHP therapy. *: p value <0.05

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us